Direct Medical Expenditures Associated with Alzheimer's and Related Dementias (ADRD) in a Nationally Representative Sample of Older Adults - an Excess Cost Approach

Overview

Journal Aging Ment Health

Publisher Routledge

Specialty Geriatrics

Date 2017 Mar 12

PMID 28282733

Citations 28

Authors

Arijita Deb

Usha Sambamoorthi

James Douglas Thornton

Bernard Schreurs

Kim Innes

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the excess direct annual healthcare expenditures associated with Alzheimer's and related dementias(ADRD) among community-dwelling older adults in the United States.

Methods: This retrospective cross-sectional study compared the annual healthcare expenditures between elderly individuals aged 65 years and older with ADRD (n = 662) and without ADRD (n = 13,398) using data from the Medical Expenditure Panel Survey (MEPS) for the years 2007, 2009, 2011 and 2013. Adjusted total annual medical expenditures was estimated using generalized linear model with gamma distribution and log link in 2013 U.S. dollars. Adjusted inpatient, outpatient, emergency, home healthcare and prescription drug expenditures, were estimated using two-part logit-generalized linear regression models.

Results: The adjusted mean total healthcare expenditures were higher for the ADRD group as compared to the no ADRD group($14,508 vs. $10,096). Among those with ADRD, 34.3% of the expenditures were for home healthcare as compared to 4.4% among those without ADRD. Among users, the ADRD group had significantly higher home healthcare ($3,240 vs. $566) and prescription drug expenditures($3,471 vs. $2,471). There were no statistically significant differences in inpatient, emergency room and outpatient expenditures between the ADRD and no ADRD group.

Conclusion: ADRD in U.S. community-dwelling elders is associated with significant financial burden, primarily driven by increased home healthcare use.

Citing Articles

Healthcare Expenditures Among Older Immigrants in the United States With Alzheimer's Disease and Related Dementias: Population-Based Study Between 2007 and 2020.

Jang S, Qin X, Park S, McCoy R, Chen J J Gerontol B Psychol Sci Soc Sci. 2024; 79(12).

PMID: 39351817 PMC: 11632365. DOI: 10.1093/geronb/gbae166.

Direct healthcare expenditure on Alzheimer's disease from healthcare providers' perspective in Malaysia: a micro-costing approach.

Ong S, Tay L, Yee T, Teh E, Chng A, Razali R Sci Rep. 2024; 14(1):18855.

PMID: 39143230 PMC: 11324753. DOI: 10.1038/s41598-024-69745-1.

Caring for Individuals with Alzheimer's Disease: A Spotlight on Hispanic Caregivers.

Garcia R, Khemka S, Roghani A, Reddy R, Pattoor V, Jacob M J Alzheimers Dis Rep. 2024; 8(1):877-902.

PMID: 38910940 PMC: 11191631. DOI: 10.3233/ADR-240035.

Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060.

Nandi A, Counts N, Broker J, Malik S, Chen S, Han R NPJ Aging. 2024; 10(1):13.

PMID: 38331952 PMC: 10853249. DOI: 10.1038/s41514-024-00136-6.

Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer's disease.

Nie B, Duan Y, Xie X, Qiu L, Shi S, Fan Z Front Aging Neurosci. 2023; 15:1204530.

PMID: 37920383 PMC: 10618683. DOI: 10.3389/fnagi.2023.1204530.

References

Mihaylova B, Briggs A, OHagan A, Thompson S . Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2010; 20(8):897-916. PMC: 3470917. DOI: 10.1002/hec.1653. View

Andersen R . Revisiting the behavioral model and access to medical care: does it matter?. J Health Soc Behav. 1995; 36(1):1-10. View

Meraya A, Sambamoorthi U . Chronic Condition Combinations and Productivity Loss Among Employed Nonelderly Adults (18 to 64 Years). J Occup Environ Med. 2016; 58(10):974-978. PMC: 5069168. DOI: 10.1097/JOM.0000000000000839. View

Hurd M, Martorell P, Delavande A, Mullen K, Langa K . Monetary costs of dementia in the United States. N Engl J Med. 2013; 368(14):1326-34. PMC: 3959992. DOI: 10.1056/NEJMsa1204629. View

Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E . Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care. 2011; 23(3):331-41. DOI: 10.1093/intqhc/mzr010. View

Aizcorbe A, Liebman E, Pack S, Cutler D, Chernew M, Rosen A . Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data. Stat J IAOS. 2015; 28(1-2):43-51. PMC: 4486327. DOI: 10.3233/SJI-2012-0743. View

Basu A, Rathouz P . Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2004; 6(1):93-109. DOI: 10.1093/biostatistics/kxh020. View

Hoffman D . Alzheimer's disease legislation and policy--now and in the future. Health Aff (Millwood). 2014; 33(4):561-5. DOI: 10.1377/hlthaff.2013.1223. View

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View

10.

Zhu C, Cosentino S, Ornstein K, Gu Y, Andrews H, Stern Y . Use and cost of hospitalization in dementia: longitudinal results from a community-based study. Int J Geriatr Psychiatry. 2014; 30(8):833-41. PMC: 4414886. DOI: 10.1002/gps.4222. View

11.

Schaller S, Mauskopf J, Kriza C, Wahlster P, Kolominsky-Rabas P . The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2014; 30(2):111-29. DOI: 10.1002/gps.4198. View

12.

Kelley A, McGarry K, Gorges R, Skinner J . The burden of health care costs for patients with dementia in the last 5 years of life. Ann Intern Med. 2015; 163(10):729-36. PMC: 4809412. DOI: 10.7326/M15-0381. View

13.

Wiener R, Long D, Jurevic R . Blood levels of the heavy metal, lead, and caries in children aged 24-72 months: NHANES III. Caries Res. 2014; 49(1):26-33. PMC: 4323869. DOI: 10.1159/000365297. View

14.

Hebert L, Weuve J, Scherr P, Evans D . Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19):1778-83. PMC: 3719424. DOI: 10.1212/WNL.0b013e31828726f5. View

15.

Zhu C, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D . Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 2006; 67(6):998-1005. DOI: 10.1212/01.wnl.0000230160.13272.1b. View

16.

Yang Z, Zhang K, Lin P, Clevenger C, Atherly A . A longitudinal analysis of the lifetime cost of dementia. Health Serv Res. 2011; 47(4):1660-78. PMC: 3307859. DOI: 10.1111/j.1475-6773.2011.01365.x. View

17.

Zuvekas S, Olin G . Accuracy of Medicare expenditures in the medical expenditure panel survey. Inquiry. 2009; 46(1):92-108. DOI: 10.5034/inquiryjrnl_46.01.92. View

18.

Langa K, Larson E, Crimmins E, Faul J, Levine D, Kabeto M . A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Intern Med. 2016; 177(1):51-58. PMC: 5195883. DOI: 10.1001/jamainternmed.2016.6807. View

19.

Plassman B, Langa K, Fisher G, Heeringa S, Weir D, Ofstedal M . Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007; 29(1-2):125-32. PMC: 2705925. DOI: 10.1159/000109998. View